NIDA Study Suggests Crystal Methamphetamine
Use in Young Adults Higher than Previously Reported
Study Also Connects Use of the Drug to Risky
Behaviors
Crystal methamphetamine use among young adults in the United States
is considerably higher than previous surveys indicate, according
to new research funded by the National Institute on Drug Abuse
(NIDA), part of the National Institutes of Health (NIH). The study,
published in the July issue of the journal Addiction,
found 2.8 percent of young adults (ages 18-26) reported use of
crystal methamphetamine in the past year during 2001-2002. This
is higher than the annual prevalence of crystal methamphetamine
use by young adults (ages 19-28) of 1.4 percent reported by NIDA’s
2002 Monitoring the Future Survey.
Previous national surveys indicate that methamphetamine prevalence
is highest among young adults, but until now, few scientific papers
have looked at the characteristics and behaviors associated with
its use in this age group. Using nationally representative data,
and examining the age group most prone to methamphetamine use (ages
18-26), the study found that young adult users are disproportionately
white and male and live in the West, and that Native Americans
were 4.2 times as likely as whites to use crystal methamphetamine.
Users also tend to have lower social economic status, use other
substances, such as alcohol, marijuana, and cocaine, and the male
users are more likely to have had incarcerated fathers.
“Measuring drug use is always a challenge,” said NIH Director
Dr. Elias A. Zerhouni. “This new information gives us a clearer
picture of use among young adults, but also raises new concerns.
Even occasional use of crystal methamphetamine is associated with
multiple health and social risks, including a negative impact on
families as well as straining emergency departments and law enforcement
resources.”
“The study showed not only greater use of crystal methamphetamine,
it also suggests the drug is associated with risky and antisocial
behaviors, including other illicit drug use,” said NIDA Director
Dr. Nora D. Volkow. “By examining these connections, we hope to
identify new avenues for treatment and prevention.”
The study authors based their findings on data from the National
Longitudinal Study of Adolescent Health (Add Health), which asked
respondents about their use of crystal methamphetamine in the past
year and past 30 days. They examined certain characteristics of
crystal methamphetamine users, such as their use of other substances,
sociodemographics, and novelty-seeking behavior. They also looked
at what was unique about crystal methamphetamine users compared
to other drug users, and the associations between past year crystal
methamphetamine use and antisocial or risk behaviors, such as crime/violence
and risky sexual behavior. To maintain confidentiality, Add Health
administered questionnaires via laptop computer using computer-assisted
self-interviewing (CASI) technology.
The study found that use of crystal methamphetamine and associations
with both criminal behavior and risky sex differed between men
and women. Associations with both types of behaviors tended to
be stronger among women than among men. Among women, the study
found crystal methamphetamine use to be significantly associated
with drug sales and risky sexual behavior, such as low condom use.
However, the authors emphasize that more research is needed to
determine whether women who sell drugs are more likely to use crystal
methamphetamine or whether use of the drug leads to criminal drug
sales among women.
Crystal methamphetamine (also referred to as “ice,” “crystal,” “glass,” and “tina”)
is a common form of methamphetamine, a highly addictive stimulant
that affects the central nervous system. As with the powdered form,
users of crystal methamphetamine are drawn to its euphoric and
stimulant effects, but the drug has higher purity and more potential
for abuse. Typically smoked, it produces an immediate, intense
sensation and has longer acting physiological effects than powder,
which also amplifies its addiction potential and adverse health
consequences. Those can include: mood disturbances, cardiovascular
problems, heat stroke, convulsions, and psychotic symptoms that
can sometimes last for months or years after methamphetamine abuse
has ceased.
“This study presents a new perspective on crystal methamphetamine
users in the United States,” said Dr. Denise D. Hallfors, of the
Pacific Institute for Research and Evaluation and a co-author on
the study. “We hope that this new information will aid in the development
of appropriate interventions and help to inform public policy.”
To date, nationally representative survey research on crystal
and other methamphetamine use has been based on two Federal sources:
Monitoring the Future (MTF), and the National Survey on Drug Use
and Health (NSDUH). In those surveys, annual prevalence of crystal
methamphetamine use was 2.1 percent among 12th graders and 1.5
percent among young adults aged 19-28 (1.8 percent for men, 1.2
percent for women). The 2004 NSDUH survey did not ask specifically
about crystal methamphetamine, but reported that past year methamphetamine
use was highest among young adults (18-25), compared to youths
and other adults.
The National Institute on Drug Abuse is a component of the National
Institutes of Health, U.S. Department of Health and Human Services.
NIDA supports most of the world's research on the health aspects
of drug abuse and addiction. The Institute carries out a large
variety of programs to ensure the rapid dissemination of research
information to inform policy and improve practice. Fact sheets
on the health effects of drugs of abuse and further information
on NIDA research can be found on the NIDA web site at http://www.drugabuse.gov.
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov.
|